Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses

被引：0
|
作者：
Aliazis, Konstantinos [1 ]
Christofides, Anthos [1 ,2 ]
Aksoylar, Halil-Ibrahim [1 ]
Shah, Rushil [1 ]
Pal, Rinku [1 ]
Patsoukis, Nikolaos [1 ,3 ]
Boussiotis, Vassiliki A. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Hematol Oncol, Boston, MA USA
[2] Yale Univ, Med, New Heaven, CT USA
[3] Simcere Amer, Cambridge, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174422
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anti-tumor effects of genetic deletion of PD-1 in adult mice
    Raghavan, Sukaya
    Tovbis, Nataliya Shifrin
    Kochel, Christina
    Malefyt, Rene deWaal
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 339 - 340
  • [2] SELECTIVE DEPLETION OF TUMOR-SPECIFIC REGULATORY T CELLS IN COMBINATION WITH LOW DOSE CHEMOTHERAPY WITH OR WITHOUT PD-1 BLOCKADE IMPROVES ANTI-TUMOR T CELL RESPONSES IN SOLID TUMORS
    Axe, Dorothee Saddier
    Kuhne, Michelle
    Jain, Renu
    Weist, Brian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A843 - A843
  • [3] Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy
    Shin, Jae Hun
    Park, Hyung Bae
    Choi, Kyungho
    IMMUNE NETWORK, 2016, 16 (02) : 134 - 139
  • [4] Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
    Guo, Xingliang
    Jiang, Hua
    Shi, Bizhi
    Zhou, Min
    Zhang, Honghong
    Shi, Zhimin
    Du, Guoxiu
    Luo, Hong
    Wu, Xiuqi
    Wang, Yi
    Sun, Ruixin
    Li, Zonghai
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [5] Differential modulation of the PD-1 pathway impacts the anti-tumor activity of CAR T cells
    Lin, Regina J.
    Gautron, Anne-Sophie
    Poirot, Laurent
    Wong, Oi Kwan
    Sasu, Barbra
    Boldajipour, Bijan
    CANCER RESEARCH, 2017, 77
  • [6] PD-1 RNA Interference Contained in a Mesothelin Chimeric Antigen Receptor T Cells Display Enhanced Anti-Tumor Activities
    Kang, Xi
    MOLECULAR THERAPY, 2019, 27 (04) : 273 - 274
  • [7] A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity
    Tao, Huimin
    Cheng, Lu
    Liu, Lihua
    Wang, Hong
    Jiang, Zhijie
    Qiang, Xu
    Xing, Lijun
    Xu, Yifeng
    Cai, Xinying
    Yao, Jing
    Wang, Min
    Qiu, Zheng
    CANCER LETTERS, 2020, 493 : 91 - 101
  • [8] Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells
    Kim, Myeong Joon
    Kim, Kyungsoo
    Park, Hyo Jin
    Kim, Gil-Ran
    Hong, Kyeong Hee
    Oh, Ji Hoon
    Son, Jimin
    Park, Dong Jin
    Kim, Dahae
    Choi, Je-Min
    Lee, Insuk
    Ha, Sang-Jun
    NATURE IMMUNOLOGY, 2023, 24 (01) : 148 - +
  • [9] Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells
    Myeong Joon Kim
    Kyungsoo Kim
    Hyo Jin Park
    Gil-Ran Kim
    Kyeong Hee Hong
    Ji Hoon Oh
    Jimin Son
    Dong Jin Park
    Dahae Kim
    Je-Min Choi
    Insuk Lee
    Sang-Jun Ha
    Nature Immunology, 2023, 24 (1) : 148 - 161
  • [10] Sintilimab: A Promising Anti-Tumor PD-1 Antibody
    Zhang, Lin
    Mai, Wuqian
    Jiang, Wenyang
    Geng, Qing
    FRONTIERS IN ONCOLOGY, 2020, 10
12345